Annual EBITDA
$804.45M$124.17M-13.37%
Summary
- Current Value
- As of today, CRL annual EBITDA is $804.45M, down -13.37% on
- Historical Performance
- CRL annual EBITDA is down -15.89% over the past 3 years, up +15.93% over the past 5 years
- All-Time High Comparison
- CRL annual EBITDA is currently -17.51% below its historical high of $975.26M set on
- 3-Year Low Comparison
- CRL annual EBITDA is at its 3-year low
- Sector Comparison
- CRL annual EBITDA is higher than 92.69% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $804.45M | -13.4% | -15.9% | +15.9% | +239.0% | |
| Quarterly EBITDA | $187.23M | -14.5% | -23.9% | -4.1% | +192.2% | |
| TTM EBITDA | $872.61M | -4.3% | -10.7% | +19.9% | +255.2% | |
| Price | $153.31 | +8.4% | -22.7% | -51.9% | +295.3% | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $4.02B | -0.8% | +1.0% | +37.3% | +254.3% | |
| Annual EPS | -$2.91 | -1560.5% | -130.7% | -140.5% | +45.9% | |
| $401.14M | -29.2% | -38.5% | -12.6% | +179.2% | ||
| Annual Net Income | -$142.16M | -662.1% | -128.9% | -138.9% | +57.5% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $975.26M | -17.5% | |
| 5Y | $975.26M | -17.5% | |
| All | $975.26M | -17.5% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $804.45M | at low | |
| 5Y | $693.88M | N/A | +15.9% |
| All | $37.67M | +2035.5% |
EBITDA History
FAQ
What is the current annual EBITDA of CRL?
As of today, CRL annual EBITDA is $804.45M
What is 1-year change in CRL annual EBITDA?
CRL annual EBITDA is down -13.37% year-over-year
What is 3-year change in CRL annual EBITDA?
CRL annual EBITDA is down -15.89% over the past 3 years
How far is CRL annual EBITDA from its all-time high?
CRL annual EBITDA is currently -17.51% below its historical high of $975.26M set on December 31, 2023
How does CRL annual EBITDA rank versus sector peers?
CRL annual EBITDA is higher than 92.69% of companies in Healthcare sector
When is CRL next annual earnings release?
As of today, the next annual earnings release for CRL has not been scheduled
Quarterly EBITDA
$187.23M$10.07M-5.10%
Summary
- Current Value
- As of today, CRL quarterly EBITDA is $187.23M, down -5.10% on
- Historical Performance
- CRL quarterly EBITDA is down -14.46% year-over-year, down -23.90% over the past 3 years
- All-Time High Comparison
- CRL quarterly EBITDA is currently -29.40% below its historical high of $265.20M set on
- 3-Year Low Comparison
- CRL quarterly EBITDA is at its 3-year low
- Sector Comparison
- CRL quarterly EBITDA is higher than 92.04% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $187.23M | -5.1% | -14.5% | -23.9% | -4.1% | |
| Annual EBITDA | $804.45M | – | -13.4% | -15.9% | +15.9% | |
| TTM EBITDA | $872.61M | -3.5% | -4.3% | -10.7% | +19.9% | |
| Price | $153.31 | -6.7% | +8.4% | -22.7% | -51.9% | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $995.83M | +0.2% | +1.2% | -3.3% | +20.8% | |
| Quarterly EPS | -$0.30 | +94.6% | -160.5% | -115.1% | -125.2% | |
| $120.08M | +0.9% | +21.9% | -28.9% | -10.2% | ||
| Quarterly Net Income | -$14.80M | +94.6% | -157.2% | -114.2% | -123.2% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $251.84M | -25.7% | |
| 3Y | $255.69M | -26.8% | |
| 5Y | $265.20M | -29.4% | |
| All | $265.20M | -29.4% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $187.23M | at low | |
| 3Y | $187.23M | at low | |
| 5Y | $187.23M | at low | |
| All | $18.26M | +925.4% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of CRL?
As of today, CRL quarterly EBITDA is $187.23M
What is CRL quarterly EBITDA most recent change?
CRL quarterly EBITDA was down -5.10% on March 28, 2026
What is 1-year change in CRL quarterly EBITDA?
CRL quarterly EBITDA is down -14.46% year-over-year
How far is CRL quarterly EBITDA from its all-time high?
CRL quarterly EBITDA is currently -29.40% below its historical high of $265.20M set on June 25, 2022
How does CRL quarterly EBITDA rank versus sector peers?
CRL quarterly EBITDA is higher than 92.04% of companies in Healthcare sector
When is CRL next earnings release?
The next earnings release for CRL is on
TTM EBITDA
$872.61M$31.65M-3.50%
Summary
- Current Value
- As of today, CRL TTM EBITDA is $872.61M, down -3.50% on
- Historical Performance
- CRL TTM EBITDA is down -4.28% year-over-year, down -10.70% over the past 3 years
- All-Time High Comparison
- CRL TTM EBITDA is currently -11.24% below its historical high of $983.08M set on
- 3-Year Low Comparison
- CRL TTM EBITDA is at its 3-year low
- Sector Comparison
- CRL TTM EBITDA is higher than 92.59% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $872.61M | -3.5% | -4.3% | -10.7% | +19.9% | |
| Annual EBITDA | $804.45M | – | -13.4% | -15.9% | +15.9% | |
| Quarterly EBITDA | $187.23M | -5.1% | -14.5% | -23.9% | -4.1% | |
| Price | $153.31 | -6.7% | +8.4% | -22.7% | -51.9% | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $4.03B | +0.3% | +0.1% | -1.6% | +32.4% | |
| TTM EPS | -$3.76 | -27.2% | -478.4% | -138.9% | -150.9% | |
| $522.51M | +4.3% | +1.5% | -22.2% | +6.9% | ||
| TTM Net Income | -$182.84M | -28.6% | -684.3% | -136.5% | -148.3% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $911.64M | N/A | -4.3% |
| 3Y | $977.13M | N/A | -10.7% |
| 5Y | $983.08M | -11.2% | |
| All | $983.08M | -11.2% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $872.61M | at low | |
| 3Y | $872.61M | at low | |
| 5Y | $727.84M | N/A | +19.9% |
| All | $20.99M | +4057.1% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of CRL?
As of today, CRL TTM EBITDA is $872.61M
What is CRL TTM EBITDA most recent change?
CRL TTM EBITDA was down -3.50% on March 28, 2026
What is 1-year change in CRL TTM EBITDA?
CRL TTM EBITDA is down -4.28% year-over-year
How far is CRL TTM EBITDA from its all-time high?
CRL TTM EBITDA is currently -11.24% below its historical high of $983.08M set on June 25, 2022
How does CRL TTM EBITDA rank versus sector peers?
CRL TTM EBITDA is higher than 92.59% of companies in Healthcare sector
When is CRL next earnings release?
The next earnings release for CRL is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- CRL Official Website www.criver.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1100682/000110068226000022/0001100682-26-000022-index.htm
- CRL Profile on Yahoo Finance finance.yahoo.com/quote/CRL
- CRL Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/crl